{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T06:36:52Z","timestamp":1770273412259,"version":"3.49.0"},"reference-count":57,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T00:00:00Z","timestamp":1745971200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"National Health and Medical Research Council Ideas","award":["#2002193"],"award-info":[{"award-number":["#2002193"]}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["#2025894"],"award-info":[{"award-number":["#2025894"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["#2016909"],"award-info":[{"award-number":["#2016909"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Aim<\/jats:title>\n                  <jats:p>To evaluate the demographic and clinical factors that influence the initiation of weak versus strong opioids among opioid-na\u00efve patients in Australian primary care settings.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This retrospective cohort study focused on opioid-na\u00efve patients, defined as those receiving an eligible opioid prescription with no prior opioid prescriptions in the prior year. The study used general practice data extracted in partnership with Primary Health Networks via the POpulation Level Analysis and Reporting (POLAR) platform. Opioid prescriptions at the time of initiation were categorized as weak or strong. We used multivariate probit model analysis to identify the demographic and clinical factors associated with type of opioid at initiation of prescribing.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>We identified 415\u200a098 opioid-na\u00efve patients in primary care between January 1, 2018, and July 31, 2023, with 17% initiated on strong opioids. The probability of initiation with a strong opioid increased in patients who were more than 80\u2009years of age by 25.0% (95%\u00a0CI: 0.244 to 0.257) compared with patients who were 20\u201329\u2009years of age. Patients with diagnoses of pain related to injury procedures (9.7% increase; 95%\u00a0CI: 0.093 to 0.101) or with prior antipsychotic prescriptions (6.2% increase; 95%\u00a0CI: 0.055 to 0.067) had higher probabilities of being prescribed strong opioids at initiation than did those without these conditions.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>One in 6 patients initiated on opioids in primary care was prescribed a strong opioid. This study highlights key factors associated with initiation of strong opioids among opioid-na\u00efve patients. Further assessment of clinical suitability and outcomes associated with strong opioid prescribing can inform our understanding of opioid use in primary care.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/pm\/pnaf053","type":"journal-article","created":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:19:56Z","timestamp":1746058796000},"page":"583-590","source":"Crossref","is-referenced-by-count":2,"title":["Understanding the first prescription: clinical and demographic drivers of strong opioid use in primary care"],"prefix":"10.1093","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-0804-9266","authenticated-orcid":false,"given":"Bishaal Tej","family":"Gurung","sequence":"first","affiliation":[{"name":"School of Medicine, Monash University , Melbourne, VIC,","place":["Australia"]},{"name":"Monash Addiction Research Centre, Eastern Clinical School, Monash University , Melbourne, VIC,","place":["Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7593-3209","authenticated-orcid":false,"given":"Louisa","family":"Picco","sequence":"additional","affiliation":[{"name":"Monash Addiction Research Centre, Eastern Clinical School, Monash University , Melbourne, VIC,","place":["Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3773-2355","authenticated-orcid":false,"given":"Grant","family":"Russell","sequence":"additional","affiliation":[{"name":"Department of General Practice, School of Public Health and Preventive Medicine, Monash University , Melbourne, VIC,","place":["Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5371-8196","authenticated-orcid":false,"given":"Christopher","family":"Pearce","sequence":"additional","affiliation":[{"name":"Outcome Health , Melbourne, VIC,","place":["Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5341-1055","authenticated-orcid":false,"given":"Suzanne","family":"Nielsen","sequence":"additional","affiliation":[{"name":"Monash Addiction Research Centre, Eastern Clinical School, Monash University , Melbourne, VIC,","place":["Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5033-6248","authenticated-orcid":false,"given":"Ting","family":"Xia","sequence":"additional","affiliation":[{"name":"Monash Addiction Research Centre, Eastern Clinical School, Monash University , Melbourne, VIC,","place":["Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,4,30]]},"reference":[{"issue":"4","key":"2025090303523473300_pnaf053-B1","doi-asserted-by":"publisher","first-page":"e335","DOI":"10.1016\/s2468-2667(22)00013-5","article-title":"Global, regional, and national trends in opioid analgesic consumption from 2015 to 2019: a longitudinal study","volume":"7","author":"Ju","year":"2022","journal-title":"Lancet Public Health"},{"issue":"1","key":"2025090303523473300_pnaf053-B2","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1038\/s41598-024-52032-4","article-title":"Reductions in sustained prescription opioid use within the US between 2017 and 2021","volume":"14","author":"Schoenfeld","year":"2024","journal-title":"Sci Rep"},{"issue":"7","key":"2025090303523473300_pnaf053-B3","doi-asserted-by":"publisher","first-page":"e41621","DOI":"10.7759\/cureus.41621","article-title":"The opioid epidemic: a review of the contributing factors, negative consequences, and best practices","volume":"15","author":"Judd","year":"2023","journal-title":"Cureus"},{"key":"2025090303523473300_pnaf053-B4","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.bpobgyn.2022.07.003","article-title":"The opioid epidemic","volume":"85(Pt B)","author":"Cook","year":"2022","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"2025090303523473300_pnaf053-B5","doi-asserted-by":"publisher","first-page":"108127","DOI":"10.1016\/j.drugalcdep.2020.108127","article-title":"Socioeconomic marginalization and opioid-related overdose: a systematic review","volume":"214","author":"van Draanen","year":"2020","journal-title":"Drug Alcohol Depend"},{"key":"2025090303523473300_pnaf053-B6","author":"WHO","year":"2023"},{"key":"2025090303523473300_pnaf053-B7","doi-asserted-by":"publisher","first-page":"104666","DOI":"10.1016\/j.drugpo.2024.104666","article-title":"Trends in prescription opioid analgesic use in Australia from 2015 to 2022","volume":"135","author":"Chidwick","year":"2025","journal-title":"Int J Drug Policy"},{"issue":"2","key":"2025090303523473300_pnaf053-B8","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s11096-024-01849-0","article-title":"Opioid prescribing prevalence and initiation rates in Victoria, Australia: insights from primary care data during a period of opioid policy changes (2017\u20132022)","volume":"47","author":"Balikci","year":"2024","journal-title":"Int J Clin Pharm"},{"key":"2025090303523473300_pnaf053-B9","author":"Australian Institute of Health and Welfare","year":"2024"},{"issue":"1","key":"2025090303523473300_pnaf053-B10","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/bcp.13792","article-title":"Prevalence and incidence of prescription opioid analgesic use in Australia","volume":"85","author":"Lalic","year":"2019","journal-title":"Br J Clin Pharmacol"},{"issue":"10","key":"2025090303523473300_pnaf053-B11","doi-asserted-by":"publisher","first-page":"e1003270","DOI":"10.1371\/journal.pmed.1003270","article-title":"Time trends and prescribing patterns of opioid drugs in UK primary care patients with non-cancer pain: a retrospective cohort study","volume":"17","author":"Jani","year":"2020","journal-title":"PLoS Med"},{"key":"2025090303523473300_pnaf053-B12","author":"Australian Bureau of Statistics","year":"2019"},{"key":"2025090303523473300_pnaf053-B13","author":"Therapeutic Goods Administration","year":"2021"},{"issue":"6","key":"2025090303523473300_pnaf053-B14","doi-asserted-by":"publisher","first-page":"315","DOI":"10.5694\/mja2.52257","article-title":"The impact of tightened prescribing restrictions for PBS-subsidised opioid medicines and the introduction of half-pack sizes, Australia, 2020\u201321: an interrupted time series analysis","volume":"220","author":"Koch","year":"2024","journal-title":"Med J Aust"},{"issue":"5","key":"2025090303523473300_pnaf053-B15","doi-asserted-by":"publisher","first-page":"299","DOI":"10.2217\/pmt-2022-0103","article-title":"Considerations for perioperative opioid analgesic stewardship in Australia: a focus on tapentadol","volume":"13","author":"Ternel","year":"2023","journal-title":"Pain Manag"},{"key":"2025090303523473300_pnaf053-B16","author":"NPS MedicineWise","year":"2016"},{"key":"2025090303523473300_pnaf053-B17","author":"Royal Australian College of General Practice","year":"2020"},{"issue":"6","key":"2025090303523473300_pnaf053-B18","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1016\/j.bja.2018.03.009","article-title":"Incidence of iatrogenic opioid dependence or abuse in patients with pain who were exposed to opioid analgesic therapy: a systematic review and meta-analysis","volume":"120","author":"Higgins","year":"2018","journal-title":"Br J Anaesth"},{"key":"2025090303523473300_pnaf053-B19","doi-asserted-by":"publisher","first-page":"e36","DOI":"10.1017\/S1463423620000365","article-title":"Factors influencing trends in opioid prescribing for older people: a scoping review","volume":"21","author":"Mikelyte","year":"2020","journal-title":"Prim Heath Care Res Dev."},{"issue":"4","key":"2025090303523473300_pnaf053-B20","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1111\/bcp.13026","article-title":"Initiation of strong prescription opioids in Australia: cohort characteristics and factors associated with the type of opioid initiated","volume":"82","author":"Gisev","year":"2016","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"2025090303523473300_pnaf053-B21","doi-asserted-by":"publisher","DOI":"10.1136\/bmjhci-2019-100009","article-title":"Coding and classifying GP data: the POLAR project","volume":"26","author":"Pearce","year":"2019","journal-title":"BMJ Health Care Inform"},{"key":"2025090303523473300_pnaf053-B22","volume-title":"Eastern Health Annual Report 2022-2023","author":"Eastern Health","year":"2023"},{"key":"2025090303523473300_pnaf053-B23","volume-title":"Monash Health Annual Report 2022-2023","author":"Monash Health","year":"2023"},{"key":"2025090303523473300_pnaf053-B24","volume-title":"Peninsula Health Annual Report 2022-2023","author":"Peninsula Health","year":"2023"},{"issue":"1","key":"2025090303523473300_pnaf053-B25","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s12913-017-2086-6","article-title":"Changes over time in prescription practices of pain medications in Switzerland between 2006 and 2013: an analysis of insurance claims","volume":"17","author":"Wertli","year":"2017","journal-title":"BMC Health Serv Res"},{"issue":"6","key":"2025090303523473300_pnaf053-B26","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1002\/pds.3945","article-title":"A synthesis of oral morphine equivalents (OME) for opioid utilisation studies","volume":"25","author":"Nielsen","year":"2016","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"6","key":"2025090303523473300_pnaf053-B27","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1097\/j.pain.0000000000003133","article-title":"Opioid characteristics and nonopioid interventions associated with successful opioid taper in patients with chronic noncancer pain","volume":"165","author":"Jung","year":"2024","journal-title":"Pain"},{"issue":"2","key":"2025090303523473300_pnaf053-B28","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1093\/pm\/pnaa322","article-title":"The prevalence of opioid analgesic use in people with chronic noncancer pain: systematic review and meta-analysis of observational studies","volume":"22","author":"Wertheimer","year":"2021","journal-title":"Pain Med"},{"issue":"9","key":"2025090303523473300_pnaf053-B29","doi-asserted-by":"publisher","first-page":"721","DOI":"10.7326\/M19-3600","article-title":"Predictors of prolonged opioid use after initial prescription for acute musculoskeletal injuries in adults","volume":"173","author":"Riva","year":"2020","journal-title":"Ann Intern Med"},{"key":"2025090303523473300_pnaf053-B30","author":"Australian Bureau of Statistics","year":"2023"},{"key":"2025090303523473300_pnaf053-B31","author":"Department of Health and Aged Care","year":"2023"},{"issue":"12","key":"2025090303523473300_pnaf053-B32","doi-asserted-by":"publisher","first-page":"4129","DOI":"10.1016\/j.sapharm.2022.07.041","article-title":"Using primary care data to understand opioid prescribing, policy impacts and clinical outcomes: a protocol for the OPPICO study","volume":"18","author":"Cangadis-Douglass","year":"2022","journal-title":"Res Social Adm Pharm"},{"issue":"5","key":"2025090303523473300_pnaf053-B33","doi-asserted-by":"publisher","first-page":"E107","DOI":"10.1503\/cmaj.190757","article-title":"Development and validation of the Cambridge Multimorbidity Score","volume":"192","author":"Payne","year":"2020","journal-title":"CMAJ"},{"issue":"731","key":"2025090303523473300_pnaf053-B34","doi-asserted-by":"publisher","first-page":"e435","DOI":"10.3399\/BJGP.2022.0235","article-title":"Development of a modified Cambridge Multimorbidity Score for use with SNOMED CT: an observational English primary care sentinel network study","volume":"73","author":"Tsang","year":"2023","journal-title":"Br J Gen Pract"},{"issue":"6","key":"2025090303523473300_pnaf053-B35","doi-asserted-by":"publisher","first-page":"e114","DOI":"10.1016\/j.bja.2018.09.019","article-title":"Evidence of opioid-induced hyperalgesia in clinical populations after chronic opioid exposure: a systematic review and meta-analysis","volume":"122","author":"Higgins","year":"2019","journal-title":"Br J Anaesth"},{"issue":"4","key":"2025090303523473300_pnaf053-B36","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1111\/ajag.13071","article-title":"A systematic review of opioid prevalence in Australian residential aged care facilities","volume":"41","author":"Dowd","year":"2022","journal-title":"Australas J Ageing"},{"issue":"5","key":"2025090303523473300_pnaf053-B37","doi-asserted-by":"publisher","first-page":"475.e1","DOI":"10.1016\/j.jpain.2017.12.001","article-title":"Efficacy and safety of oral and transdermal opioid analgesics for musculoskeletal pain in older adults: a systematic review of randomized, placebo-controlled trials","volume":"19","author":"Megale","year":"2018","journal-title":"J Pain"},{"issue":"1","key":"2025090303523473300_pnaf053-B38","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1177\/8755122519867975","article-title":"Opioid prescribing in the elderly: a systematic review","volume":"36","author":"Jassal","year":"2020","journal-title":"J Pharm Technol"},{"issue":"12","key":"2025090303523473300_pnaf053-B39","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1007\/s40266-021-00893-z","article-title":"Problematic opioid use among older adults: epidemiology, adverse outcomes and treatment considerations","volume":"38","author":"Dufort","year":"2021","journal-title":"Drugs Aging"},{"issue":"2","key":"2025090303523473300_pnaf053-B40","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1093\/schbul\/sbab116","article-title":"Risk of overdose associated with co-prescription of antipsychotics and opioids: a population-based cohort study","volume":"48","author":"Szmulewicz","year":"2022","journal-title":"Schizophr Bull"},{"issue":"2","key":"2025090303523473300_pnaf053-B41","doi-asserted-by":"publisher","first-page":"273","DOI":"10.2147\/cia.s1847","article-title":"Opiates and elderly: use and side effects","volume":"3","author":"Chau","year":"2008","journal-title":"Clin Interv Aging"},{"issue":"2","key":"2025090303523473300_pnaf053-B42","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1093\/pm\/pnac113","article-title":"Pain, opioid analgesics, and cognition: a conceptual framework in older adults","volume":"24","author":"Warner","year":"2023","journal-title":"Pain Med"},{"issue":"5","key":"2025090303523473300_pnaf053-B43","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1002\/pds.3931","article-title":"The extent and correlates of community-based pharmaceutical opioid utilisation in Australia","volume":"25","author":"Degenhardt","year":"2016","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2025090303523473300_pnaf053-B44","author":"Department of Health","year":"2024"},{"issue":"5","key":"2025090303523473300_pnaf053-B45","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1071\/AH15047","article-title":"Health service utilisation by people living with chronic non-cancer pain: findings from the Pain and Opioids IN Treatment (POINT) study","volume":"40","author":"Nielsen","year":"2016","journal-title":"Aust Health Rev"},{"issue":"8","key":"2025090303523473300_pnaf053-B46","doi-asserted-by":"publisher","first-page":"305","DOI":"10.5694\/mja16.00066","article-title":"Using opioids in general practice for chronic non-cancer pain: an overview of current evidence","volume":"204","author":"Currow","year":"2016","journal-title":"Med J Aust"},{"key":"2025090303523473300_pnaf053-B47","author":"Faculty of Pain Medicine","year":"2020"},{"key":"2025090303523473300_pnaf053-B48","author":"NSW Ministry of Health","year":"2022"},{"issue":"2","key":"2025090303523473300_pnaf053-B49","doi-asserted-by":"publisher","first-page":"85","DOI":"10.7326\/0003-4819-152-2-201001190-00006","article-title":"Opioid prescriptions for chronic pain and overdose: a cohort study","volume":"152","author":"Dunn","year":"2010","journal-title":"Ann Intern Med"},{"issue":"16","key":"2025090303523473300_pnaf053-B50","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1001\/archinternmed.2010.273","article-title":"Emergency department visits among recipients of chronic opioid therapy","volume":"170","author":"Braden","year":"2010","journal-title":"Arch Intern Med"},{"issue":"1","key":"2025090303523473300_pnaf053-B51","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1186\/s12889-021-11162-4","article-title":"Quantifying prescribed high dose opioids in the community and risk of overdose","volume":"21","author":"Schofield","year":"2021","journal-title":"BMC Public Health"},{"issue":"7","key":"2025090303523473300_pnaf053-B52","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/j.mayocp.2016.04.029","article-title":"Chronic pain and mental health disorders: shared neural mechanisms, epidemiology, and treatment","volume":"91","author":"Hooten","year":"2016","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"2025090303523473300_pnaf053-B53","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s11920-018-0872-4","article-title":"Psychiatry and pain management: at the intersection of chronic pain and mental health","volume":"20","author":"Goesling","year":"2018","journal-title":"Curr Psychiatry Rep"},{"issue":"5","key":"2025090303523473300_pnaf053-B54","doi-asserted-by":"publisher","first-page":"e067746","DOI":"10.1136\/bmjopen-2022-067746","article-title":"Cohort profile: using primary care data to understand Opioid Prescribing, Policy Impacts and Clinical Outcomes (OPPICO) in Victoria, Australia","volume":"13","author":"Nielsen","year":"2023","journal-title":"BMJ Open"},{"key":"2025090303523473300_pnaf053-B55","doi-asserted-by":"publisher","first-page":"104189","DOI":"10.1016\/j.ijmedinf.2020.104189","article-title":"Harnessing the potential of electronic general practice pathology data in Australia: an examination of the quality use of pathology for type 2 diabetes patients","volume":"141","author":"Imai","year":"2020","journal-title":"Int J Med Inform"},{"key":"2025090303523473300_pnaf053-B56","author":"Australian Commission on Safety and Quality in Health Care","year":"2021"},{"key":"2025090303523473300_pnaf053-B57","author":"Australian Commission on Safety and Quality in Health Care","year":"2022"}],"container-title":["Pain Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/painmedicine\/advance-article-pdf\/doi\/10.1093\/pm\/pnaf053\/63037343\/pnaf053.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/painmedicine\/article-pdf\/26\/9\/583\/63037343\/pnaf053.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/painmedicine\/article-pdf\/26\/9\/583\/63037343\/pnaf053.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T07:52:41Z","timestamp":1756885961000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/painmedicine\/article\/26\/9\/583\/8123383"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,30]]},"references-count":57,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,4,30]]},"published-print":{"date-parts":[[2025,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/pm\/pnaf053","relation":{},"ISSN":["1526-2375","1526-4637"],"issn-type":[{"value":"1526-2375","type":"print"},{"value":"1526-4637","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,9]]},"published":{"date-parts":[[2025,4,30]]}}}